✦ LIBER ✦

Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging

✍ Scribed by Kiyoshi Ohara; Yumiko Oishi Tanaka; Hajime Tsunoda; Masato Nishida; Shinji Sugahara; Yuji Itai

Book ID: 117191082
Publisher: Lippincott Williams and Wilkins
Year: 2002
Tongue: English
Weight: 138 KB
Volume: 100
Category: Article
ISSN: 0029-7844
DOI: 10.1016/s0029-7844(02)02204-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

668 poster Objective assessment of cervi

668 poster Objective assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Serum squamous cell carcinoma antigen le

Serum squamous cell carcinoma antigen levels in invasive cervical cancer: Prediction of response and recurrence

✍ Rose, Peter G.; Baker, Stephen; Fournier, Lawrence; Nelson, Beth E.; Hunter, Ric 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 599 KB

Serum Squamous Cell Carcinoma Antigen as

Serum Squamous Cell Carcinoma Antigen as a Surrogate for Cervical Tumor Volume Defined on Brachytherapy Planning Magnetic Resonance Imaging During Definitive Chemoradiation Therapy

✍ Henke, L.; Markovina, S.; Dyk, P.; Price, S.; DeWees, T.; Grigsby, P.W. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Improvement of Clinical Staging in Cervi

Improvement of Clinical Staging in Cervical Cancer with Serum Squamous Cell Carcinoma Antigen and CA 125 Determinations

✍ Leon F.A.G. Massuger; Norbert P. Koper; Chris M.G. Thomas; Koen E.L. Dom; Charle 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Clinical value of pretreatment serum Cyf

Clinical value of pretreatment serum Cyfra 21–1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer

✍ Katja N. Gaarenstroom; Johannes M. G. Bonfrer; Gemma G. Kenter; Catharina M. Kor 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Serum level of squamous cell carcinoma a

Serum level of squamous cell carcinoma antigen and tumor size are useful to identify preoperatively patients at high risk of cervical cancer

✍ Cheng-Yang Chou; Shan-Tair Wang; Hong-Chang Kuo; Ching-Cherng Tzeng; Bor-Lin Yao 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

## Background: The benefit of postoperative adjuvant therapy for patients with cervical cancer is uncertain, and moreover, may increase morbidity. in this study, patient age, clinical stage of the cancer, tumor size, and levels of serum squamous cell carcinoma cell antigen and carcinoembryonic anti